Synthetic Biology Companies

Funding Frenzy and Acquisitions: Twist Bioscience Raises $200 Million in Series H Round: In October 2023, this DNA synthesis leader secured significant funding to expand its manufacturing capacity and advance its synthetic biology technologies.

Ginkgo Bioworks Acquires Synlogic Therapeutics: This November 2023 acquisition strengthens Ginkgo's cell engineering capabilities and expands its pipeline of potential therapeutic solutions.

CRISPR-based Malaria Vaccine Candidate Progress: SynBio company Synpromics and the Wellcome Sanger Institute unveiled promising results for their synthetic biology-based vaccine candidate against malaria.

Bioprinting Tissues for Transplantation: Researchers at MIT successfully bioprinted a miniature, functional human heart ventricle using synthetic biology techniques, raising hopes for future organ transplantation solutions.

• Bota Biosciences Inc.


• Codexis Inc.


• Creative Biogene


• CREATIVE ENZYMES


• Enbiotix Inc.


• Illumina Inc.


• Merck Kgaa (Sigma-Aldrich Co. LLC)


• New England Biolabs


• Eurofins Scientific


• Novozymes Pareto Bio, Inc.


• Scarab Genomics, LLC


• Synthego


• Synthetic Genomics Inc.


• Thermo Fisher Scientific, Inc.